2018-09-04T16:59:04-05:00 2017-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2017-01-01 390807235 BloodCenter of Wisconsin Inc % PAUL MATSON BLOO 4149335000 PO Box 2178 638 North 18th St Milwaukee WI 532012178 CHRIS MISKEL President & CEO 4149335000 2018-08-31 true Michelle L Weber P00556798 4142898200 2018-08-24 2017 2022-09-23 18:48:47Z CHRIS MISKEL 638 N 18th St Milwaukee WI 532012178 177724337 false X WWW.BCW.EDU X 1947 WI RECRUITS BLOOD, STEM CELLS, ORGAN, TISSUE PROVIDES BLOOD, DIAGNOSTIC LAB TESTING, CLINICAL SERVICES & SPECIALTY PHARMACEUTICALS. CONDUCTS RESEARCH. STRIVES TO PROTECT PUBLIC SAFETY. 15 14 1097 339 0 0 22122317 22711570 139695965 133670650 1122914 2030510 32847 51690 162974043 158464420 2285244 5106386 0 0 76922259 76388086 0 0 0 75965640 75353894 155173143 156848366 7800900 1616054 149956733 145257751 45625862 36460919 104330871 108796832 X RECRUITS BLOOD, STEM CELLS, ORGAN AND TISSUE DONATIONS. PROVIDES BLOOD, DIAGNOSTIC LAB TESTING, CLINICAL SERVICES & SPECIALTY PHARMACEUTICALS. CONDUCTS RESEARCH. STRIVES TO PROTECT PUBLIC SAFETY. false false 40450295 17790 51326960 BLOODCENTER OF WISCONSIN, INC. FULFILLS ITS TAX-EXEMPT PURPOSE BY RECRUITING VOLUNTEER BLOOD DONORS, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND STABLE SOURCE FOR CUSTOMERS AT THE 57 HOSPITALS AND OTHER BLOOD CENTERS WE SUPPLY. IN THE YEAR ENDED 2017, 169,408 DONORS COLLECTED 190,000 productive UNITS OF BLOOD TO PATIENTS IN NEED. 27718859 4590195 0 IN THE INTERCONNECTED WORLD OF SCIENCE AND MEDICINE RESEARCH IS CRITICAL. BLOODCENTER OF WISCONSIN'S RESEARCH, PART OF OUR VISISON SINCE INCEPTION IN 1947, SPANS BASIC, TRANSLATIONAL AND CLINCIAL RESEARCH THAT FOCUSES ON BLOOD AND BLOOD DISORDERS. OUR RESEARCH DISCOVERIES MAKE TANGIBLE CONTRIBUTIONS TO THE CARE OF PATIENTS. 23309353 0 34731467 BLOODCENTER OF WISCONSIN, INC. FULFILLS ITS TAX-EXEMPT PURPOSE OF PROVIDING DIAGNOSTIC LABORATORY TESTING IN THE AREAS OF HISTOCOMPATIBILITY, TRANSPLANT SEQUENCING, MOLECULAR DIAGNOSTICS, CORE ISOLATION, PLATELET & NEUTROPHIL IMMUNOLOGY, HEMOSTASIS REFERENCE, IMMUNOHEMATOLOGY REFERENCE, TRANSFUSION SERVICES, MOLECULAR ONCOLOGY, RED CELL GENOTYPING AND GENOMICS. 21647369 116201 24973916 COMPREHENSIVE CENTER FOR BLEEDING DISORDERS 12024612 12200 14064190 ORGAN AND TISSUE DONATIONS 8834966 370000 8574117 MEDICAL SERVICES 0 0 55159 OTHER REVENUE 42506947 498401 47667382 133985454 true true false true false false false false false true true false false false true true false true false false true false false false false false false true false true true false false false false false false false false false false false false false false false true false false false true 172 0 true 1097 true false false false false false false false false false false X 15 14 true false false false true true true true true false false true true true true true true true true false WI X X PAUL MATSON 4149376349 638 N 18TH ST Milwaukee WI 532332121 X Chris Miskel President & CEO - as of 2/2017 32.0 23.0 X X 385003 231003 33085 Jacquelyn Fredrick President & CEO - thru 2/2017 51.0 4.0 X X 917617 0 1518 Richard J Fotsch Chairman 1.0 4.0 X X 0 0 0 L Alan Whaley Vice Chairman 1.0 4.0 X X 0 0 0 Mitchell G Watt Secretary 1.0 3.0 X X 0 0 0 James M Rauh Treasurer 1.0 4.0 X X 0 0 0 Cathy Buck Board Member 1.0 3.0 X 0 0 0 Fred Geilfuss Board Member 1.0 3.0 X 0 0 0 Thomas Hauske JR Board Member 1.0 3.0 X 0 0 0 Dale Kent Board Member 1.0 3.0 X 0 0 0 Gregory Larkin Board Member 1.0 4.0 X 0 0 0 Robert H Manegold Board Member 1.0 4.0 X 0 0 0 Jeffrey S McDonald Board Member 1.0 3.0 X 0 0 0 John Perras Board Member 1.0 3.0 X 0 0 0 E Randall Wright Board Member 1.0 4.0 X 0 0 0 Peter Ziegler Board Member 1.0 4.0 X 0 0 0 Thomas Abshire MD EVP MSI & Chief Med Officer 55.0 0.0 X 610424 0 23766 Ilke Panzer EVP & chief innovation officer 55.0 0.0 X 534552 0 33078 Gilbert C White MD Executive VP of Research 37.0 18.0 X 461046 216963 35109 Anthony Watkins EVP & Chief Financial Officer 38.0 17.0 X 360306 154416 38681 James Mitchell SR VP Blood Services 39.0 16.0 X 287344 123148 38535 Maureen Kwiecinski EVP & General Counsel 30.0 25.0 X 255374 208944 21635 Lynne Briggs VP & Chief Information officer 33.0 22.0 X 207835 138555 39820 Margaret McElligott VP & Chief Quality Officer 34.0 21.0 X 190358 107082 33768 Sandi Lemons VP & Chief HR - thru 6/17 23.0 32.0 X 166969 232479 22275 Gitesh Dubal VP & Chief Marketing Officer 55.0 0.0 X 126840 0 3147 James Weidner VP & Chief HR - as of 9/17 22.0 33.0 X 45677 68517 3147 Michael Frohna - thru 917 Chief Philanthropy Officer 0.0 55.0 X 0 238286 29370 Peter Newman PHD VP Research & Assoc Dir BRI 55.0 0.0 X 420257 0 29834 Jerome Gottschall MD VP Medical Services 55.0 0.0 X 352829 0 35108 Mehraboon Irani MD Medical Dir of therapeutic svs 55.0 0.0 X 351337 0 37980 Kenneth Friedman MD Medical Director 55.0 0.0 X 323217 0 35108 Joshua Field MD Medical Director 55.0 0.0 X 308748 0 30853 6305733 1719393 525817 99 false true false MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RoaD MILWAUKEE WI 53226 MEDICAL SERVICES 1953322 BIOMEDICAL RESOURCE CENTER 8701 WATERTOWN PLANK ROAD MILWAUKEE WI 53226 MEDICAL RESEARCH 853807 FROEDTERT HEALTH 9200 W WISCONSIN AVENUE MILWAUKEE WI 53226 MEDICAL SERVICES 852938 AURORA HEALTH CARE INC PO BOX 341100 ITASCA IL 53234 MEDICAL SERVICES 695877 Creative Testing Solutions 2424 W Erie Drive TEMPE AZ 85282 medical testing 447106 36 7469871 12521591 2720108 22711570 BLOOD SERVICES 621500 51326960 51326960 DIAGNOSTIC LABORATORIES 621500 34731467 34731467 PHARMACY 621500 24973916 24973916 ORGAN AND TISSUE DONATION 621500 14064190 14064190 MEDICAL SERVICES 621500 8574117 8574117 133670650 1785274 1785274 0 0 30000 34464 -4464 0 -4464 -4464 19449660 21029 18999503 225950 450157 -204921 245236 245236 0 0 0 0 0 0 0 0 0 INSURANCE INTEREST 900099 20578 20578 SUPPORT OF FACILITIES AT MRMC - DOT 561000 19087 19087 SUPPORT OF RADIATION ASSESSMENT 561000 15494 15494 995 995 56154 158464420 133725809 2027041 5106386 5106386 0 0 0 4777434 1516139 3261295 0 57364064 49090416 8273648 3974086 3391059 583027 6224267 5269872 954395 4048235 3395293 652942 0 299861 75889 223972 280681 280681 0 0 51291 51291 18537764 16854854 1682910 0 415262 228361 186901 1397071 1162257 234814 2274901 943566 1331335 24673 24673 4527407 2923151 1604256 806640 748263 58377 0 1671465 1365535 305930 84960 84960 0 4936818 3037049 1899769 388500 50564 337936 PHARMACEUTICAL PRODUCTS 21154331 21154331 MEDICAL LAB SUPPLIES 15531493 15531493 COST OF IMPORTS 471360 471360 DONOR COST 382010 382010 2117406 1262933 854473 156848366 133985454 22862912 0 200000 200000 30256156 12622972 0 0 24817855 24447739 0 0 0 0 0 0 5601744 6623174 1309631 1323339 104261803 65874460 39059304 38387343 48683792 61645133 0 0 0 0 0 0 28251 8051 149956733 145257751 29751132 29271308 0 0 0 0 3802023 3175668 0 0 0 0 0 0 0 0 12072707 4013943 45625862 36460919 X 104330871 108796832 0 0 0 0 104330871 108796832 149956733 145257751 X 1616054 4049258 -1199351 X false true X true true true X 17934403 19235934 20381758 22122317 22711570 102385982 0 0 17934403 19235934 20381758 22122317 22711570 102385982 36776420 65609562 707545 604827 677004 1163577 1815274 4968227 0 0 0 0 0 0 0 0 0 0 0 0 107354209 683866913 0.61115 0.66691 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false false true 1002 1002 false OTHER ACTIVITIES PART II-B, LINE II $1,002 OF THE DUES PAID TO THE ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS HAS BEEN ALLOCATED TO LOBBYING. 76439806 2294914 11411375 4100370 86045725 72401518 793676 7045041 3800429 76439806 81135521 471114 -5788954 3416163 72401518 81439963 1466377 1316637 2937763 149693 81135521 74174152 362882 9536701 2460513 173259 81439963 1.00000 false true true 0 2716472 2716472 0 62561542 36704235 25857307 0 808803 565872 242931 0 32419336 23641546 3072115 0 5755650 4962807 6498518 38387343 0 LONG TERM PENSION OBLIGATIONS 3971211 ADDITIONAL INCENTIVES 42732 4013943 X 161502421 4049258 -1199351 2849907 158652514 51291 -239385 -188094 158464420 157036460 239385 239385 156797075 51291 51291 156848366 Part V ENDOWMENTS THE FILING ORGANIZATION IS A BENEFICIARY OF THE BLOODCENTER RESEARCH FOUNDATION'S ("BCRF") ENDOWMENT AS A SUPPORTED ORGANIZATION. THE BOARD DESIGNATED ENDOWMENT FUNDS ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES. PART X Income Taxes Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation have all received tax determination letters confirming that the organizations qualify as tax-exempt organizations under section 501(c)(3) of the Internal Revenue Code (IRC). The Organization follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation are exempt from federal income tax under IRC section 501(c)(3), though they are subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the IRC. The Organization has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. BloodCenter and the Foundation have filed federal and state of Wisconsin income tax returns to report unrelated business income through 2009 and are no longer subject to tax authority examinations for years prior to 2010 under the federal and state statute. Management has determined that there is no unrelated business income to report for BloodCenter or the Foundation for 2010 through 2017, and income tax returns are not required to be filed. Therefore, as the statute of limitations will remain open for returns not filed, tax years 2010 through 2017, will remain open to audit for both federal and state purposes. Michigan has not historically filed any unrelated business income tax returns; therefore, tax years remain open for years in which an income tax return has not been filed. In years prior to 2014, heartland filed both federal and state of Illinois income tax returns to report a zero amount of unrelated business income. Management has determined that there is no unrelated business income to report for Heartland for tax years 2014 through 2017, and income tax returns are not required to be filed; therefore, as the statute of limitations will remain open for returns not filed, tax years 2014 through 2017, will remain open to audit for both federal and state purposes. In years prior to 2014, Indiana filed federal unrelated business income tax returns to report a zero amount of unrelated business income. In 2014 through 2016, Indiana filed federal and Indiana returns to report an unrelated business loss. The statute of limitations will remain open for both federal and state purposes for any returns not filed. Versiti has not filed any unrelated business income tax returns; therefore they years since 2012, the year of inception, are still open to examination. The Organization has determined that there are no material uncertain tax positions that require recognition or disclosure in the consolidated financial statements. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the years ended December 31, 2017 and 2016. On December 22, 2017, tax reform legislation commonly known as the Tax Cuts and Jobs Act of 2017 (the Act) was passed; resulting in significant modifications to existing tax law. There were no material effects on the Organization's financial statements as a result of the Act. Management is evaluating the ongoing impact of the Act on the Organization. Part XI, Line 2d Reconciliation of Revenue Additional Minimum Pension Benefit $(1,199,351) Part XI, Line 4b OTHER ADJUSTMENTS Rental Activity Expenses $(34,464) Loss on Asset Sale (204,921) --------- Total (239,385) Part XII, Line 2d Reconciliation of Expenses Rental Activity Expenses $34,464 Loss on Asset Sale 204,921 --------- Total 239,385 true North America Program Services RESEARCH GRANT 253609 253609 253609 false false false false false false true BLOODCENTER RESEARCH FOUNDATION INC 638 NORTH 18TH STREET MILWAUKEE WI 53233 391372542 501(C)(3) 4565195 0 RESEARCH BLOODCENTER RESEARCH FOUNDATION INC 638 NORTH 18TH STREET MILWAUKEE WI 53233 391372542 501(C)(3) 370000 0 MEDICAL SERVICES GREAT LAKES HEMOPHILIA FOUNDATION INC 638 NORTH 18TH STREET MILWAUKEE WI 53233 237367636 501(C)(3) 106201 0 PATIENT FINANCIAL AS NATIONAL BLOOD FOUNDATION 8101 GLENBROOK ROAD BETHESDA MD 20814 362384118 501(C)(3) 25000 RESEARCH 3 Part I, Line 2 PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. BLOODCENTER OF WISCONSIN, INC. CONTINUES TO PROVIDE GRANT FUNDING TO BLOODCENTER RESEARCH FOUNDATION, INC. AND OTHER TAX-EXEMPT ORGANIZATIONS. THESE FUNDS WILL SUPPORT FUTURE BLOOD RESEARCH AND OTHER INITIATIVES TO SERVE MORE PATIENTS AND REDUCE OVERALL COSTS. MONITORING THE INVESTMENT OF THESE FUNDS, THE DISTRIBUTIONS AND WHAT THESE FUNDS ARE USED FOR IS COMPLETED BY LEADERSHIP OF BLOODCENTER OF WISCONSIN, INC. X true true X X X X X true true false false false false false true false Chris Miskel President & CEO - as of 2/2017 301638 180984 71875 43125 11490 6894 12101 7260 8579 5145 405683 243408 0 0 Jacquelyn Fredrick President & CEO - thru 2/2017 160546 0 385241 0 371830 0 1187 0 331 0 919135 0 328455 0 Thomas Abshire MD EVP MSI & Chief Med Officer 448049 0 139167 0 23208 0 21600 0 2166 0 634190 0 0 0 Ilke Panzer EVP & chief innovation officer 384507 0 131493 0 18552 0 19579 0 13499 0 567630 0 0 0 Gilbert C White MD Executive VP of Research 342905 161367 103736 48817 14405 6779 14688 6912 9186 4323 484920 228198 0 0 Anthony Watkins EVP & Chief Financial Officer 260125 111483 98756 42324 1425 609 13848 5934 13229 5670 387383 166020 0 0 James Mitchell SR VP Blood Services 214305 91845 71859 30797 1180 506 13745 5891 13229 5670 314318 134709 0 0 Maureen Kwiecinski EVP & General Counsel 185208 151536 59584 48753 10582 8655 10395 8505 1505 1230 267274 218679 0 0 Lynne Briggs VP & Chief Information officer 155818 103877 50459 33640 1558 1038 12562 8373 11331 7554 231728 154482 0 0 Margaret McElligott VP & Chief Quality Officer 132359 74454 44348 24948 13651 7680 13048 7338 8564 4818 211970 119238 0 0 Sandi Lemons VP & Chief HR - thru 6/17 69135 96260 31564 43946 66270 92273 1838 2558 7474 10405 176281 245442 0 0 Michael Frohna - thru 917 Chief Philanthropy Officer 0 183285 0 54186 0 815 0 15280 0 14090 0 267656 0 0 Peter Newman PHD VP Research & Assoc Dir BRI 312145 0 78681 0 29431 0 22314 0 7520 0 450091 0 0 0 Jerome Gottschall MD VP Medical Services 312920 0 16443 0 23466 0 21600 0 13508 0 387937 0 0 0 Mehraboon Irani MD Medical Dir of therapeutic svs 331535 0 16500 0 3302 0 19681 0 18299 0 389317 0 0 0 Kenneth Friedman MD Medical Director 286148 0 14506 0 22563 0 21600 0 13508 0 358325 0 0 0 Joshua Field MD Medical Director 293030 0 15000 0 718 0 11968 0 18885 0 339601 0 0 0 Part I, Line 1a BUSINESS CLUB DUES BLOODCENTER OF WISCONSIN, INC. PROVIDES BUSINESS CLUB MEMBERSHIPS FOR THE FOLLOWING EMPLOYEES: -JACQUELYN FREDRICK -GILBERT WHITE THE CLUB MEMBERSHIPS ARE NOT TREATED AS TAXABLE COMPENSATION. THE EMPLOYEES USE THESE MEMBERSHIPS FOR BUSINESS MEETINGS OFF SITE AND BUSINESS LUNCHES/DINNERS. ANY PERSONAL EXPENSES INCURRED AT THE CLUB ARE PAID FOR DIRECTLY BY THE EMPLOYEES OR THE EMPLOYEES REIMBURSE THE ENTITY FOR PERSONAL EXPENSES. Part I, Line 4a Severance Payments An individual left the organization in 2017. The individual received severance in 2017, which is included on Schedule J, Part II, Column B(iii). Due to confidentiality agreements, neither the name nor the amount will be listed. Part I, Line 4b SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN TO ENSURE BLOODCENTER OF WISCONSIN, INC. ACHIEVES ITS MISSION, IT IS ESSENTIAL TO ATTRACT LEADING EXPERTS IN TRANSFUSION MEDICINE, SCIENCE AND BUSINESS BY PAYING COMPETITIVE SALARIES AND BENEFITS. BLOODCENTER OF WISCONSIN, INC. BOARD OF DIRECTORS FOLLOWS NOT-FOR-PROFIT BEST PRACTICES BY HIRING AN INDEPENDENT COMPENSATION CONSULTANT TO ANNUALLY REVIEW THE OVERALL EXECUTIVE COMPENSATION PROGRAMS. JACQUELYN FREDRICK, CEO, PARTICIPATED IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP). THE AMOUNT PAID AND INCLUDED IN SCHEDULE J, PART II, COLUMN B(III) DURING 2017 IN SERVICE OF THE SERP PLAN WAS $352,643, WHICH INCLUDES $328,455 THAT WAS PREVIOUSLY REPORTED AS DEFERRED COMPENSATION ON SCHEDULE J, PART II, COLUMN C. Part I, Line 7 Non-Fixed Payments Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation; the incentive payout is subject to the review of accomplishments/ objectives and the ultimate determination of incentive compensation is subject to President / CEO and Executive Committee of the Board approval. A WI Health Educational Facilities Authority (1994A) 391337855 2009-08-19 7145000 proceeds used to currently refund false false false A 3950000 0 7145000 0 0 0 0 0 0 0 0 0 1989 true false true true A 0 A false false false true true false 0 false 0 false false A true Sch K Part IV Line 2c Part IV, Line 2C Rebate Calculation A REBATE CALCULATION WAS LAST PERFORMED ON 7/29/2011 FOR THE WHEFA 1994A BOND. Part III, Line 4d Other Program Services BloodCenter of Wisconsin, Inc. fulfills its tax-exempt purpose in three ways: A. BLOOODCENTER OF WISCONSIN, INC. (BCW) OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVES TO BLEEDING & CLOTTING DISORDER PATIENTS & THEIR FAMILIES. AS A COVERED ENTITY UNDER THE FEDERAL 340b DRUG DISCOUNT PROGRAM, BCW IS ELIGIBLE TO ACCESS CERTAIN PHARMACEUTICALS AT DISCOUNTED PRICING. PHARMACEUTICAL NET INCOME IS PROGRAM INCOME & FUNDS ARE RESTRICTED TO ACTIVITIES & EXPENDITURES THAT FURTHER ELIGIBLE PROJECTS & PROGRAM OBJECTIVES, INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, APPROVED GRANT RESEARCH & OTHER COSTS. B. Organ and Tissue Donation combines procurement services and education to enhance the lives of patients and provides guidance to the families of potential donors. C. Medical Sciences Institute provides medical services including consultation with hospitals we serve, special patient services for patients with unique blood disorders including providing community education programs for medical professionals through routine lecture series and the specialist in blood banking programs. PART VI, SECTION A, LINE 2 Business Relationship DALE KENT AND PETER ZIEGLER HAVE A BUSINESS RELATIONSHIP. Part VI, Section A, Line 6 Members or Stockholders VERSITI, Inc. IS THE SOLE CORPORATE MEMBER. Part VI, SECTION A, Lines 7a and 7b Member or Stockholder Powers VERSITI, Inc. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. PART VI, SECTION B, LINE 11B Form 990 Review BLOODCENTER OF WISCONSIN UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE CONTROLLER, SR. VICE PRESIDENT AND CFO AND THE PRESIDENT AND CEO. THE DRAFT FORMS ARE THEN REVIEWED BY THE COMPLIANCE AND AUDIT COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. PART VI, SECTION B, LINE 12c Conflict of Interest Policy BLOODCENTER OF WISCONSIN MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH BLOODCENTER OF WISCONSIN. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH BLOODCENTER OF WISCONSIN. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH BLOODCENTER OF WISCONSIN. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY. Part VI, SECTION B, LINES 15A AND 15B Compensation Process Versiti and its affiliated blood centers greatly value the generous contributions of the individuals and organizations that support our mission within the community we serve. In order to ensure proper stewardship of our charitable resources, Versiti and its affiliates follow a formalized process to confirm that compensation provided to our executive leadership team is fair, reasonable, and not excessive when compared to other executives. This process also helps us ensure that our compensation program supports the retention of experienced, highly-qualified executives who are committed to our mission. The Compensation Committee of the Versiti Board of Directors, acting in its capacity as the Compensation Committee, sets and monitors the compensation philosophy for Versiti and the related entities that it supports, including BloodCenter of Wisconsin (BCW). Other than the Versiti President and Chief Executive Officer, the Compensation Committee does not include members of management and is comprised entirely of individuals who do not have a conflict of interest with respect to Versiti compensation arrangements. The Versiti President and Chief Executive Officer recuses her/himself from all discussions and approvals related to her/his compensation. The Versiti Compensation Committee reviews executive compensation arrangements to ensure such arrangements are fair, reasonable, and not excessive when compared to similarly-situated executives. Executive compensation arrangements are reviewed for reasonableness and approved by the Compensation Committee annually in accordance with the Versiti Reasonableness Review Policy. In order to assess the reasonableness of executive compensation arrangements, the Compensation Committee obtains and reviews appropriate comparability data collected by the human resource department and a qualified independent compensation consultant. The Compensation Committee engages a qualified independent compensation consultant annually. The independent consultant performs an analysis of compensation levels at regional and national organizations of comparable size, scope and structure; and provides the Committee with comprehensive data on the availability of similar services within the geographic area, compensation surveys, written offers from similar institutions, and other information relevant to comparability of compensation. The Compensation Committee's review, recommendations and approvals are documented concurrently in the Committee minutes, which are subsequently reviewed and approved by the Compensation Committee as reasonable, accurate and complete. A copy of the Compensation Committee's minutes is also provided to the Versiti Board of Directors. Versiti and BCW have incentive programs for executives, directors, management, investigators and staff described in detailed written policies approved by the Compensation Committee annually. Evaluation and compensation review -CEO - Each year, the Executive/Compensation Committee evaluates the CEO's performance against established objectives, determines incentive payment and merit increase based upon performance and market data provided by the third party compensation consultant, and works with the CEO to establish objectives for the next year. -Executives - Each year, the Versiti/BCW CEO reviews the performance of each executive and the achievement of their individual goals and objectives. The Versiti/BCW CEO presents his/her recommendations to the Compensation Committee, which reviews and approves recommended compensation ranges, and approves final salary and incentive payments. Executives are positioned within the appropriate salary range based upon the: -executive's knowledge, competencies, and experience, -performance of the executive's areas of responsibility, -the executive's contribution to overall performance, -the importance of retaining the executive, -internal equity considerations, -the financial resources available, and -executive base salary increases provided in the competitive market. Part VI, SECTION C, LINE 19 Organization's Documents Open to the Public THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST TO THE PUBLIC. VIEWING IS DONE ON THE ORGANIZATION'S PREMISES. Part VII Average Hours The hours listed on Form 990, Part VII are representative of an average for the officers and executive team. Each individual person's weekly tally may be greater or lesser per week based on their individual roles and responsibilities within the filing organization and related parties. The salary presented for the President and CEO is reflective of total salary compensation for services to the filing organization and related affiliates. Part IX, Line 9 OTHER CHANGES IN NET ASSETS PENSION ADJUSTMENT ($1,199,351) FORM 990 PART IX LINE 11G DESCRIPTION:DONOR TESTING TOTAL FEES:8263332 FORM 990 PART IX LINE 11G DESCRIPTION:OPERATING ROOM TOTAL FEES:1006780 FORM 990 PART IX LINE 11G DESCRIPTION:POSTAGE/SHIPPING TOTAL FEES:1146158 FORM 990 PART IX LINE 11G DESCRIPTION:SUBCONTRACTORS TOTAL FEES:822199 FORM 990 PART IX LINE 11G DESCRIPTION:ERP CONSULTING FEES TOTAL FEES:698434 FORM 990 PART IX LINE 11G DESCRIPTION:LAB SERVICES TOTAL FEES:684847 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED SERVICES TOTAL FEES:496377 FORM 990 PART IX LINE 11G DESCRIPTION:ICU TOTAL FEES:486418 FORM 990 PART IX LINE 11G DESCRIPTION:PHARMACY TOTAL FEES:441154 FORM 990 PART IX LINE 11G DESCRIPTION:BABESIA TOTAL FEES:419193 FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTANT TOTAL FEES:366077 FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE LAB SERVICES TOTAL FEES:343741 FORM 990 PART IX LINE 11G DESCRIPTION:CLAIMS BILLING TOTAL FEES:280395 FORM 990 PART IX LINE 11G DESCRIPTION:CARDIOLOGY TOTAL FEES:262550 FORM 990 PART IX LINE 11G DESCRIPTION:ANESTHESIA TOTAL FEES:246427 FORM 990 PART IX LINE 11G DESCRIPTION:SECURITY TOTAL FEES:242422 FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE FRINGE BENEFITS TOTAL FEES:218553 FORM 990 PART IX LINE 11G DESCRIPTION:FACILITIES TOTAL FEES:209343 FORM 990 PART IX LINE 11G DESCRIPTION:RESPIRATORY THERAPISTS TOTAL FEES:188436 FORM 990 PART IX LINE 11G DESCRIPTION:RADIOLOGY TOTAL FEES:168904 FORM 990 PART IX LINE 11G DESCRIPTION:PHYSICIANS TOTAL FEES:162841 FORM 990 PART IX LINE 11G DESCRIPTION:MEDICAL TRANSPORT TOTAL FEES:161037 FORM 990 PART IX LINE 11G DESCRIPTION:CUSTOM TESTING TOTAL FEES:151409 FORM 990 PART IX LINE 11G DESCRIPTION:MEDICAL DIRECTOR TOTAL FEES:127500 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER FEES TOTAL FEES:943237 BloodCenter Research Foundation Inc PO Box 2178 638 North 18th Milwaukee WI 53201 391372542 Supporting WI 501(c)(3) 12B Versiti false Versiti Inc PO Box 2178 638 North 18th Milwaukee WI 53201 454675354 Supporting WI 501(c)(3) 12B NA false Aurora Area Blood Bank dba Heartland 1200 N Highland Avenue Aurora IL 60506 364179758 Blood IL 501(c)(3) 10 Versiti false Michigan Blood PO Box 1704 Grand Rapids MI 49501 381550001 Blood MI 501(c)(3) 10 Versiti false Central Indiana Regional Blood Center 3450 North Meridian Street Indianapolis IN 46208 350991629 Blood IN 501(c)(3) 10 Versiti false false true true false false false false false false false false true true true true false true false false